- Home
- IHRT vs TNGX Comparison
IHRT vs TNGX Comparison
Compare IHRT & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- TNGX
- Stock Information
- Founded
- IHRT 1974
- TNGX 2014
- Country
- IHRT United States
- TNGX United States
- Employees
- IHRT N/A
- TNGX N/A
- Industry
- IHRT Broadcasting
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- TNGX Health Care
- Exchange
- IHRT Nasdaq
- TNGX Nasdaq
- Market Cap
- IHRT 193.4M
- TNGX 351.2M
- IPO Year
- IHRT 2019
- TNGX N/A
- Fundamental
- Price
- IHRT $2.03
- TNGX $6.01
- Analyst Decision
- IHRT Buy
- TNGX Strong Buy
- Analyst Count
- IHRT 3
- TNGX 6
- Target Price
- IHRT $2.92
- TNGX $12.20
- AVG Volume (30 Days)
- IHRT 780.4K
- TNGX 2.7M
- Earning Date
- IHRT 08-07-2025
- TNGX 08-06-2025
- Dividend Yield
- IHRT N/A
- TNGX N/A
- EPS Growth
- IHRT N/A
- TNGX N/A
- EPS
- IHRT N/A
- TNGX N/A
- Revenue
- IHRT $3,862,595,000.00
- TNGX $40,990,000.00
- Revenue This Year
- IHRT N/A
- TNGX N/A
- Revenue Next Year
- IHRT $5.89
- TNGX N/A
- P/E Ratio
- IHRT N/A
- TNGX N/A
- Revenue Growth
- IHRT 3.31
- TNGX 10.09
- 52 Week Low
- IHRT $0.95
- TNGX $1.03
- 52 Week High
- IHRT $2.84
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- IHRT 73.86
- TNGX 76.36
- Support Level
- IHRT $1.64
- TNGX $5.34
- Resistance Level
- IHRT $2.13
- TNGX $6.40
- Average True Range (ATR)
- IHRT 0.13
- TNGX 0.50
- MACD
- IHRT 0.02
- TNGX -0.02
- Stochastic Oscillator
- IHRT 87.76
- TNGX 84.08
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.